Twist Bioscience Beats Q4 Estimates on Revenue and Earnings
Twist Bioscience Corporation (NASDAQ:TWST) on November 14, 2025, announced a fourth-quarter fiscal 2025 earnings per share of -$0.44, which was narrower than the consensus estimate of a -$0.50 loss. The company also posted quarterly revenue of approximately $99 million, surpassing the analyst estimate of $97.4 million.
The reported revenue marked a significant increase from the $84.71 million recorded in the same quarter of the previous year. This result represents the fourth consecutive quarter in which Twist Bioscience has exceeded consensus revenue estimates. The figure surpassed the Zacks Consensus Estimate by 1.69%.
Despite the beat against estimates, the quarterly loss of $0.44 per share was wider than the Zacks Consensus Estimate of a $0.40 loss. However, it reflects an improvement from the prior-year quarter's loss of $0.59 per share.
Financially, the company shows a price-to-sales ratio of about 4.21. Twist Bioscience maintains a debt-to-equity ratio of approximately 0.16 and a current ratio of around 3.64, suggesting a solid position to cover its short-term liabilities. For more information on the company, see its financial health and investor profile.
Twist Bioscience, a provider of synthetic DNA-based products, operates within the biomedical and genetics sector. Additional details can be found regarding the company's history and ownership and its mission and vision.
Twist Bioscience Corporation (TWST) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.